DOJ Secures Six Medicare Fraud Convictions Totaling $1.1B in Three Weeks
The Justice Department's Health Care Fraud Unit convicted six defendants in a blistering three-week trial sprint that exposed schemes ranging from an industrialized telehealth platform bilking $1 billion to a physician who out-billed every other Medicare provider in America for Botox injections.
In a display of prosecutorial force that signals the DOJ's transformation into a data-driven enforcement juggernaut, federal prosecutors secured six trial convictions in six separate federal districts within 21 days, collectively exposing over $1.1 billion in Medicare fraud. The announcements came June 4, 2026, marking what the Justice Department characterized as "extraordinary" trial activity that goes well beyond simple volume to demonstrate a new investigative methodology that has fundamentally changed how the government hunts fraudsters.
The cases reveal a disturbing sophistication in modern Medicare fraud: industrialized schemes that exploit elderly beneficiaries at scale, physicians gaming billing algorithms through statistical outlier manipulation, and conspiracies that weaponize telemedicine infrastructure and foreign call centers.
The headline case involves HealthSplash founder and CEO Brett Blackman, 42, who orchestrated what Acting Attorney General Todd Blanche called "one of the most egregious fraud schemes in Florida history." Blackman owned DMERx, an internet platform that prosecutors allege transformed Medicare fraud into an industrial operation. The scheme worked like this: foreign call centers blasted spam mailers targeting hundreds of thousands of Medicare's most vulnerable—elderly beneficiaries living on fixed incomes—pressuring them into accepting medically unnecessary orthotic braces. When patients agreed, DMERx connected the leads to telemedicine companies that paid illegal kickbacks in exchange for signing bogus physicians' orders claiming that doctors had personally examined patients, when in many cases the doctor never spoke with them at all.
A government undercover agent posed as a Medicare beneficiary and documented the scheme in real time. The agent was pushed into multiple braces by a foreign call center operator, then a DMERx doctor signed orders claiming to have conducted in-person tests that are physically impossible to perform remotely. The scheme generated over $1 billion in false billings, of which Medicare paid more than $450 million. Blackman and his co-conspirators concealed the conspiracy by manipulating physicians' orders to evade Medicare audits and using sham contracts to disguise kickback flows.
Blackman was convicted of health care fraud conspiracy, kickback conspiracy, and conspiracy to defraud the United States. His co-defendant Gary Cox, who ran DMERx, was convicted at a prior trial and sentenced to 15 years in prison.
The second conviction—and perhaps the one that reveals the DOJ's new investigative power—involved Dr. Violetta Mailyan of California, a case that prosecutors began not with a tip from a whistleblower or patient complaint, but with a data anomaly. The Health Care Fraud Unit's Data Analytics Team flagged Mailyan as a statistical extreme: she had been paid more by Medicare for Botox injections than any other physician in the United States, collecting more than $24 million from the program. The government's proactive data-driven lead led to convictions on fabrication of medical records and obstruction charges when Mailyan back-dated patient consent forms and altered documents upon learning that a grand jury subpoena was en route. Post-conviction forfeiture orders revealed assets including a Tesla Model X, a Tesla Cybertruck, brokerage accounts totaling over $7.3 million, and four California properties.
The third conviction involved Ruby Scott, a licensed nurse and owner of Delta Home Health Care LLC in Michigan, who built her patient pipeline by corrupting a hospital discharge nurse. The nurse used her hospital access to identify Medicare patients and transmit their confidential records to Delta without their knowledge or consent. The conspiracy involved identity theft and kickback schemes worth tens of millions.
Three additional convictions rounded out the sweep: a home health kickback network involving false identities, a durable medical equipment scheme, and a provider network that exploited vulnerable populations through upcoding and services-not-rendered fraud.
What makes these convictions significant goes beyond the aggregate dollar amounts. The Justice Department has completed nine trials to date in 2026, all resulting in convictions, maintaining an extraordinary pace of white-collar trial activity. In 2025, the Health Care Fraud Unit completed 17 trials. This productivity reflects not just volume but a fundamental shift in enforcement strategy: away from whistleblower-dependent investigations toward proactive data analytics that flag outliers before complaints arrive.
The DOJ's Health Care Fraud Data Fusion Center, announced earlier this year, brings together data specialists from multiple agencies with a mandate to institutionalize this statistical outlier methodology. The message is unambiguous: if your billing deviates significantly from national benchmarks, you will be identified, investigated, and prosecuted—regardless of whether a qui tam whistleblower ever comes forward.
For schemes involving wound care, genetic testing, durable medical equipment, and telehealth—categories that the DOJ has flagged as high-risk—the statistical targeting is already operational. One clinic, Expert Wound Care PC in Pasadena, had $2 million seized in April 2026 after its billing patterns triggered automated alerts: it billed at more than double the national average per claim, with utilization rates six times higher than normal, and one patient alone received $6.2 million in payments.
The convictions announced June 4 represent the apex of this transformation. Six distinct schemes. Six convictions. $1.1 billion in exposed fraud. Zero reliance on traditional informant networks. Pure statistical analysis feeding prosecution teams data-driven leads that older investigative models would have missed entirely.
The implication for healthcare providers is stark: opacity is no longer protection. The DOJ's data analytics capabilities have made billing pattern forensics a standard prosecution tool. If you are an outlier—in utilization rates, in per-claim averages, in beneficiary concentration, in telemedicine ordering patterns—you are visible. And if you are visible to the Health Care Fraud Unit's analysts, a grand jury subpoena is likely only a data meeting away.
I spent nine years chasing benefits fraudsters. We relied on whistleblowers, tips, and luck. What the DOJ announced yesterday—six convictions in 21 days across multiple circuits—isn't just volume. It's proof that the enforcement equation has flipped. Outliers used to hide in noise. Now they illuminate themselves in the data. If you're billing at 2x or 6x the national average, if your utilization rates defy statistical reality, if one patient is your revenue engine, you're already flagged. The Analytics Team has your file. The grand jury subpoena is pending. The prosecutors are building the case. What the DOJ has weaponized isn't new law or creative interpretation—it's math. And healthcare providers everywhere are just now realizing that billing opacity, the old protection racket, has evaporated. If you're an outlier, you're a target. That's the future of Medicare enforcement. Winners: DOJ, taxpayers, the 9 in 2026 who got convicted. Losers: Every provider thinking statistical gravity works in their favor. It doesn't.
Cross-reference independently — don't take our word for it.
Disclosure: NewsAnarchist uses AI-assisted reporting with web search. Always verify primary sources linked above.